Rockwell Medical is a biopharma offering an anemia therapy called Triferic®, only FDA approved drug indicated to replace iron and maintain hemoglobin in hemodialysis patients. Triferic® replaces the 5-7mg iron loss occurring in patients at each dialysis session, maintains iron balance without increasing ferritin, & overcomes toxicity & infections associated with IV iron. Triferic® is delivered via dialysate saving considerable nursing time. Rockwell also offers Calcitriol vitamin-D-injection and CitraPure® citric-based concentrate. Visit www.triferic.com and www.rockwellmed.com.